Skip to main content
OpenTrials
Completed

NCT Number: NCT02585739

Cluster Headache and SPINK-1 Gene

Cluster headache (CH) is a rare, excruciating primary headache disorder. A genetic basis has been suggested by family and twin studies, but the mode of transmission seems to vary and the amount of heritability is unclear.

The number of genetic association studies investigating variants implicated in the pathophysiology of CH is limited. The HCRTR2 1246G > A and the ADH4 925A > G polymorphisms have been associated with CH. The former has been confirmed and may affect the hypothalamic hypocretin system. The aim of the present study was to investigate the possible link between SPINK 1 gene and cluster headache.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • People aged 18 or over
  • Patient consulting in Marseille's or Nice's Pain departments
  • Patient agreeing to participate to the research study
  • Patient with health insurance

Exclusion criteria

  • People aged under 18
  • Patient refusing to participate to the research study
  • Patient with deprivation of liberty

Treatment and study plan

blood sample

Genetic

Primary outcomes

  1. SPINK1 genotyping

    Time frame: 2 months

Sponsors and collaborators

Lead sponsor

Assistance Publique Hopitaux De Marseille

Other

Registry information

Important dates

Study start
2011
Primary completion
2013
Study completion
2015
First posted
Oct 23, 2015
Registry last updated
Oct 23, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.